Source: MdLinx, March 2019 In this prospective study, researchers assessed the effectiveness of both regular clinical examination and ultrasound surveillance of regional lymph node basins in patients with intermediate-thickness cutaneous melanoma. They recruited 90 patients with melanoma with a 1.2–3.5 mm thickness who had under-gone wide local excision but not sentinel node biopsy to a […]
Archive | Scientific Publications
Prospective cohort study of ultrasound surveillance of regional lymph nodes in patients with intermediate-risk cutaneous melanoma
Posted in Melanoma News, Health Professionals, Of Interest, Publications, Scientific Publications
Uveal melanoma incidence trends in Canada: a national comprehensive population-based study
Source: BMJ, March 2019
Posted in Melanoma News, Health Professionals, Of Interest, Publications, Scientific Publications
Prospective cohort study of ultrasound surveillance of regional lymph nodes in patients with intermediate-risk cutaneous melanoma
Source: MDLinx, March 2019 In this prospective study, researchers assessed the effectiveness of both regular clinical examination and ultrasound surveillance of regional lymph node basins in patients with intermediate-thickness cutaneous melanoma. They recruited 90 patients with melanoma with a 1.2–3.5 mm thickness who had under-gone wide local excision but not sentinel node biopsy to a […]
Posted in Melanoma News, Health Professionals, Of Interest, Publications, Scientific Publications
FDA Approves Adjuvant Pembrolizumab in Stage III Melanoma
Source: OncLive, March 2019 The FDA has approved the PD-1 inhibitor pembrolizumab (Keytruda) for the adjuvant treatment of patients with high-risk stage III melanoma with lymph node involvement following complete resection.1 This is the first anti–PD-1 therapy evaluated in the adjuvant setting across patients with stage IIIA, stage IIIB, and stage IIIC melanoma. The approval is […]
Posted in Melanoma News, Publications, Scientific Publications
